Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
CEChembio Diagnostics, Inc. logo

Chembio Diagnostics, Inc. (CEMI)

NASDAQ Capital Market · Currency in USD
$0.46 ▲ +0.00 (+0.22%)
At close: Apr 27, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.45
Open
$0.45
Day's Range
$0.46 – $0.46
52 Week Range
$0.19 – $1.24
Volume
351,642
Avg. Volume
538,392
Market Cap
$16.71M
Beta (5Y Monthly)
1.86
PE Ratio (TTM)
--
EPS (TTM)
-$0.96
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Chembio Diagnostics, Inc.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Full-time employees
188
CEO
Richard L. Eberly

Chembio Diagnostics, Inc., along with its subsidiaries, specializes in creating, producing, and bringing to market point-of-care (POC) diagnostic tests used for identifying and diagnosing various diseases. Their current product offerings include tests for critical conditions like COVID-19, HIV/Syphilis, and the Zika virus. Beyond these, the company is dedicated to advancing diagnostics for a wide array of other infectious diseases, such as malaria, dengue, chikungunya, Chagas disease, Ebola, leishmaniasis, Lassa fever, Marburg virus, leptospirosis, rickettsia, and Burkholderia infections.

Earnings

DateEst.Actual
Mar 29, 2023–-$0.02
Nov 3, 2022–-$0.21
Aug 4, 2022–-$0.23
May 5, 2022-$0.21-$0.29Miss
Mar 3, 2022-$0.23-$0.32Miss
Nov 4, 2021-$0.21-$0.23Miss

Analyst view

Rating: Hold
Buy 33% · Hold 67% · Sell 0%

Get free alerts on CEMI and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.